☰

Fu Gui - Publications

Affiliations: 
2012-2016 School of Life Sciences, Xiamen University 
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Tsujino T, Takai T, Hinohara K, Gui F, Tsutsumi T, Bai X, Miao C, Feng C, Gui B, Sztupinszki Z, Simoneau A, Xie N, Fazli L, Dong X, Azuma H, et al. CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature Communications. 14: 252. PMID 36650183 DOI: 10.1038/s41467-023-35880-y  0.336
2022 Zhang CS, Li M, Wang Y, Li X, Zong Y, Long S, Zhang M, Feng JW, Wei X, Liu YH, Zhang B, Wu J, Zhang C, Lian W, Ma T, ... ... Gui F, et al. The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK. Nature Metabolism. PMID 36217034 DOI: 10.1038/s42255-022-00640-7  0.463
2022 Miao C, Tsujino T, Takai T, Gui F, Tsutsumi T, Sztupinszki Z, Wang Z, Azuma H, Szallasi Z, Mouw KW, Zou L, Kibel AS, Jia L. loss overrides PARP inhibitor sensitivity driven by loss in prostate cancer. Science Advances. 8: eabl9794. PMID 35179959 DOI: 10.1126/sciadv.abl9794  0.33
2021 Lu Y, Fan Z, Zhu SJ, Huang X, Zhuang Z, Li Y, Deng Z, Gao L, Hong X, Zhang T, Li L, Sun X, Huang W, Zhang J, Liu Y, ... ... Gui F, et al. A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLC. Embo Molecular Medicine. e14296. PMID 34845836 DOI: 10.15252/emmm.202114296  0.678
2020 Li W, Ni H, Wu S, Han S, Chen C, Li L, Li Y, Gui F, Han J, Deng X. Targeting RIPK3 oligomerization blocks necroptosis without inducing apoptosis. Febs Letters. PMID 32412649 DOI: 10.1002/1873-3468.13812  0.673
2019 Gui F, Jiang J, He Z, Li L, Li Y, Deng Z, Lu Y, Wu X, Chen G, Su J, Song S, Zhang YM, Yun CH, Huang X, Weisberg E, et al. A non-covalent inhibitor XMU-MP-3 overrides ibrutinib-resistant Btk mutation in B-cell malignancies. British Journal of Pharmacology. PMID 31364164 DOI: 10.1111/Bph.14809  0.704
2016 Jiang J, Gui F, He Z, Li L, Li Y, Li S, Wu X, Deng Z, Sun X, Huang X, Huang W, Han S, Zhang T, Wang Z, Jiao B, et al. Targeting BRK-positive breast cancers with small molecule kinase inhibitors. Cancer Research. PMID 27758886 DOI: 10.1158/0008-5472.Can-16-1038  0.521
2015 Wang Y, Qi S, Zhan Y, Zhang N, Wu AA, Gui F, Guo K, Yang Y, Cao S, Hu Z, Zheng Z, Song S, Xu Q, Shen Y, Deng X. Aspertetranones A-D, Putative Meroterpenoids from the Marine Algal-Associated Fungus Aspergillus sp. ZL0-1b14. Journal of Natural Products. PMID 26378981 DOI: 10.1021/Acs.Jnatprod.5B00487  0.416
Show low-probability matches.